The global market for personalized retail nutrition and wellness is valued at $3.94 billion in 2024. It is expected to grow to $4.54 billion by 2025 and reach approximately $16.25 billion by 2034. This market is expanding at a compound annual growth rate (CAGR) of 15.22% from 2025 to 2034. The increase in health and wellness awareness among consumers is a key factor driving this growth.
Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5396
The personalized retail nutrition and wellness market focuses on creating and selling nutrition and wellness supplements designed to improve health or maintain a healthy lifestyle. As nutrition-related issues become more widespread, there is a growing need for targeted solutions. Tailored nutrition, which adapts to an individual’s specific needs, is gaining popularity as a way to improve health and maintain balance. Research has shown that genetic variations can affect how nutritional supplements work, highlighting the importance of customizing nutrition based on genetic makeup. This trend aligns with the rapidly advancing fields of genomics and nutrigenetics.
In 2025, technological advancements, evolving consumer preferences, and an increasing focus on personal health are expected to drive growth and innovation in this market. Companies are investing more in understanding their customers, developing products that address specific health concerns, and offering solutions that cater to individual lifestyles.
Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/personalized-retail-nutrition-and-wellness-market-sizing
Access exclusive insight now @ https://www.towardshealthcare.com/price/5396
We’ve prepared a service to support you. Please feel free to contact us at sales@towardshealthcare.com
Web: https://www.towardshealthcare.com
Visit Dental Specifics: https://www.towardsdental.com
Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription
For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
Kedrion Biopharma has announced that its human coagulation factor X concentrate, COAGADEX®, has been granted orphan drug designation by the… Read More
enecard PBF, a pioneer in pharmacy benefit facilitation, has announced a strategic partnership with DecisionRX, Inc., a leader in medication… Read More
In a high-stakes biotech industry where drug development can span over a decade, four small but determined biotech companies are… Read More
cell-free DNA and precision medicine, has officially announced the launch of the TEODOR trial (ABCSG 61), a groundbreaking phase 2,… Read More
The global interventional radiology market is witnessing rapid expansion, driven by advancements in minimally invasive procedures, rising demand for diagnostic… Read More
The global physical therapy market is valued at USD 28.06 billion in 2024, growing to USD 29.18 billion in 2025… Read More